Jupiter Endovascular has completed patient enrolment in the SPIRARE II pivotal clinical trial of its Vertex pulmonary ...

Avantec Vascular, a Nipro company, announced FDA 510(k) clearance of its thrombectomy system, which is intended for the treatme ...

Jupiter Endovascular announced that it completed patient enrollment in the SPIRARE II pivotal clinical trial evaluating its Vertex system.

Alteplase, a “clot-buster” medication used to treat ischemic stroke, acute myocardial infarctions, and acute pulmonary ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global pulmonary embolectomy system market is poised for significant expansion, with valuation expected to increase from USD 1,509.72 Million in 2026 to ...

iPhone's "System Data" can take up a lot of space on your smartphone. Here's what we know. Credit: Future Publishing via Getty Images It's a dreaded notification that some iPhone users have come to ...

The phase III trial studying CRISPR gene editing therapy for transthyretin amyloidosis (ATTR) was paused for safety due to an alarming case of poor liver function in one patient, Intellia Therapeutics ...

Jupiter Endovascular, which was formed by Neptune Medical a little more than a year ago, shared positive results from the first-in-human trial of its Vertex TFX catheter platform. As part of its ...

Jupiter Endovascular, Inc., a medical technology company developing a new class of endovascular interventions using its proprietary Transforming Fixation (TFX) technology, today announced positive ...

Round Led by Sonder Capital with Participation from Senvest Management, LB Investment, and a New Strategic Corporate Investor MENLO PARK, Calif.--(BUSINESS WIRE)-- Jupiter Endovascular, Inc., a ...

Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using its proprietary Transforming Fixation (TFX) technology, today announced it has closed ...

Medical technology startup Jupiter Endovascular has closed on a round of Series B funding, surpassing its $40 million goal. The funding was led by investor group Sonder Capital, which has also ...